On June 26, 2025, CPHI & PMEC China 2025 successfully concluded at the Shanghai New International Expo Centre. As one of Asia’s leading pharmaceutical industry events, the exhibition brought together global stakeholders across APIs, intermediates, excipients, formulations, and pharmaceutical equipment, providing a key platform for industry exchange and cooperation.

The HS team attended the exhibition and presented a range of core APIs, intermediates, and functional excipients, while introducing the company’s capabilities in quality control, stable supply, regulatory support, and customized services. During the event, the team engaged in in-depth discussions with clients and partners from various international markets, exploring new collaboration opportunities and strengthening existing business relationships.

Participation in CPHI & PMEC China 2025 further expanded HS’s global network and supported the company’s ongoing international market development. Moving forward, HS remains committed to delivering reliable pharmaceutical materials and building long-term partnerships worldwide.